The ICVS and 3B’s will work together in a multidisciplinary way to address the challenges of cancer burden, specifically to i) boost and overcome resistance to cancer therapy and identify new biomarkers of response, by targeting cellular crosstalk in the tumour ecosystem and ii) develop novel 3D Cancer Disease Models, Bioprinting & Microfluidics based technologies, and nanomedicine-based approaches for cancer theranostics.